Both Wegovy and Ozempic were on the U.S. Food and ... U.S. law prohibits compounders from making or selling "knockoff 'semaglutide drugs' with rare exceptions." "Moving forward, any compounder ...

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

Novo Nordisk reduced its starter dose prices through telehealth platforms to encourage patients to wean themselves off compounded copycats.

Semaglutide is the key ingredient in Novo's weight-loss drug Wegovy and Type 2 diabetes drug Ozempic. Novo announced ... any entity that mass produces or sells knockoff semaglutide is breaking ...

Ozempic maker Novo Nordisk pushed out ... the door to U.S. compounding pharmacies to make lower-cost knockoff versions of Novo’s drugs, adding to the competitive pressures.

The shortage of semaglutide injections (Ozempic, Wegovy ... due to misinformation and reach for fake or illegitimate knockoff drugs that pose significant safety risks to patients," he added.

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

Patients taking weight-loss medicines such as Novo Nordisk A/S’s Ozempic and Wegovy are at risk of developing an eye ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer. By Rebecca Robbins Novo Nordisk will replace its ...

Now, there are rumblings on social media from patients and doctors suggesting that weight-loss drugs could be linked to tooth decay and gum issues like irritation and bleeding. Ozempic teeth ...